Stay updated on INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedUpdated to revision v3.0.2, replacing v3.0.1. The removal of the 'Back to Top' element is a minor UI change; there are no substantive changes to core content, pricing, or availability.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has updated its facility name and location details, specifically changing the representation of Chūōku, Japan, and has added drug information for Retifanlimab. Additionally, the revision number has been updated to v3.0.0.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page.